nefiracetam has been researched along with bisindolylmaleimide i in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuoka, T; Matsuyama, S; Nishizaki, T; Nomura, T; Shiotani, T; Watabe, S; Yoshii, M | 1 |
| Enikolopo, G; Enikolopov, G; Kondoh, T; Matuoka, T; Nishizaki, T; Nomura, T; Shiotani, T; Sumikawa, K; Watabe, S; Yoshii, M | 1 |
2 other study(ies) available for nefiracetam and bisindolylmaleimide i
| Article | Year |
|---|---|
A 'long-term-potentiation-like' facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam.
Topics: 2-Amino-5-phosphonovalerate; Animals; Bicuculline; Bungarotoxins; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Hippocampus; Indoles; Isoquinolines; Kainic Acid; Long-Term Potentiation; Maleimides; Mecamylamine; N-Methylaspartate; Nicotinic Antagonists; Nootropic Agents; Organ Culture Techniques; Patch-Clamp Techniques; Pyrrolidinones; Rats; Receptors, Nicotinic; Sulfonamides; Synaptic Transmission | 1999 |
The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors.
Topics: Animals; Cells, Cultured; Central Nervous System Agents; Denervation; Enzyme Inhibitors; Glutamic Acid; Hippocampus; Indoles; Maleimides; Presynaptic Terminals; Protein Kinase C; Pyrrolidinones; Rats; Receptors, Nicotinic; Synaptic Transmission | 2000 |